Revvity (NYSE:RVTY) Price Target Raised to $110.00 at Wells Fargo & Company

Revvity (NYSE:RVTY) had its target price boosted by Wells Fargo & Company from $107.00 to $110.00 in a research note released on Tuesday morning,Benzinga reports. The brokerage currently has an equal weight rating on the stock.

A number of other research analysts have also recently issued reports on RVTY. The Goldman Sachs Group assumed coverage on shares of Revvity in a research note on Tuesday, December 9th. They issued a “neutral” rating and a $105.00 target price for the company. Evercore ISI lifted their price objective on Revvity from $112.00 to $118.00 and gave the company an “outperform” rating in a research report on Tuesday. Guggenheim started coverage on Revvity in a report on Wednesday, October 15th. They set a “neutral” rating on the stock. Robert W. Baird raised their target price on Revvity from $122.00 to $123.00 and gave the company an “outperform” rating in a research note on Tuesday, October 28th. Finally, Barclays upped their price target on shares of Revvity from $115.00 to $118.00 and gave the stock an “overweight” rating in a research report on Tuesday. Five analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $113.67.

Revvity Trading Down 5.8%

Shares of RVTY opened at $100.85 on Tuesday. The stock has a 50 day simple moving average of $103.99 and a 200-day simple moving average of $95.57. The company has a current ratio of 1.68, a quick ratio of 1.44 and a debt-to-equity ratio of 0.36. The stock has a market cap of $11.43 billion, a PE ratio of 48.49, a PEG ratio of 3.22 and a beta of 1.07. Revvity has a 1 year low of $81.36 and a 1 year high of $124.82.

Revvity (NYSE:RVTY) last issued its quarterly earnings data on Monday, February 2nd. The company reported $1.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.55 by $0.15. The company had revenue of $772.06 million during the quarter, compared to analysts’ expectations of $759.81 million. Revvity had a return on equity of 7.92% and a net margin of 8.45%.The business’s revenue was up 5.9% on a year-over-year basis. During the same period last year, the business earned $1.42 earnings per share. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. On average, sell-side analysts predict that Revvity will post 4.94 EPS for the current fiscal year.

Revvity declared that its Board of Directors has authorized a share repurchase program on Monday, October 27th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the company to repurchase up to 8.7% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s leadership believes its stock is undervalued.

Revvity Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 8th. Shareholders of record on Friday, April 17th will be paid a $0.07 dividend. This represents a $0.28 annualized dividend and a yield of 0.3%. The ex-dividend date of this dividend is Friday, April 17th. Revvity’s dividend payout ratio is presently 14.07%.

Hedge Funds Weigh In On Revvity

Institutional investors and hedge funds have recently modified their holdings of the business. Byrne Asset Management LLC lifted its position in shares of Revvity by 0.9% during the 4th quarter. Byrne Asset Management LLC now owns 11,138 shares of the company’s stock worth $1,078,000 after buying an additional 100 shares during the last quarter. Trust Point Inc. grew its position in Revvity by 3.8% in the fourth quarter. Trust Point Inc. now owns 3,215 shares of the company’s stock valued at $311,000 after acquiring an additional 117 shares during the last quarter. First National Advisers LLC raised its stake in Revvity by 0.8% during the third quarter. First National Advisers LLC now owns 15,023 shares of the company’s stock worth $1,317,000 after acquiring an additional 125 shares in the last quarter. Farther Finance Advisors LLC lifted its holdings in shares of Revvity by 26.2% in the fourth quarter. Farther Finance Advisors LLC now owns 698 shares of the company’s stock worth $68,000 after acquiring an additional 145 shares during the last quarter. Finally, Mackenzie Financial Corp boosted its stake in shares of Revvity by 1.7% in the 3rd quarter. Mackenzie Financial Corp now owns 8,955 shares of the company’s stock valued at $785,000 after purchasing an additional 154 shares in the last quarter. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Revvity

Here are the key news stories impacting Revvity this week:

• Positive Sentiment: Revvity reported stronger-than-expected Q4 results: adjusted EPS $1.70 (above estimates) and revenue $772.1M (+5.9% YoY). Management raised FY‑2026 guidance (EPS $5.35–5.45; revenue ~ $3.0B), which sits slightly above consensus. These beats and the raised guidance are the primary fundamental positives supporting the stock. Reuters: Revvity forecasts 2026 profit, revenue above estimates
• Positive Sentiment: Multiple analysts lifted price targets after the results — TD Cowen to $124 (buy), Wells Fargo to $110 (equal weight), and JPMorgan to $105 (neutral) — signaling continued analyst support and upside in some research houses. The Fly: TD Cowen raise Benzinga: analyst notes
• Neutral Sentiment: Full earnings call transcript, slide deck and presentation are available for deeper review — useful for assessing segment trends (diagnostics strength vs. academic research weakness) but neutral until investors digest details. Seeking Alpha: Q4 transcript
• Neutral Sentiment: Analyst/market commentary highlights Revvity as a momentum name and reviews key metrics vs. estimates — useful framing for traders but not new primary drivers. Zacks: momentum piece
• Negative Sentiment: Despite the positive news, shares fell today — trading volume was above average — suggesting profit-taking, short‑term rotation, or valuation concerns (RVTY’s trailing P/E is elevated). The market may be pricing a higher bar for sustained upside even after the beat and upgrades.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.